Diffuse large B-cell lymphoma in a patient with rheumatoid arthritis treated with infliximab and methotrexate

Clinical and Experimental Dermatology

Volumn 33, Issue 4, 2008, Pages 437-439

  Nakashima, C ^a   Tanioka, M ^a   Takahashi, K ^a   Miyachi, Y ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; DOXORUBICIN; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; RITUXIMAB; VINCRISTINE;

ABDOMINAL RADIOGRAPHY; ADULT; ANAMNESIS; ARTICLE; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LOW DRUG DOSE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SKIN BIOPSY; SKIN EXAMINATION; TREATMENT RESPONSE;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG INCOMPATIBILITY; FEMALE; HUMANS; LIVER NEOPLASMS; LYMPHOMA, LARGE B-CELL, DIFFUSE; METHOTREXATE; MIDDLE AGED; SKIN NEOPLASMS; THORACIC WALL; TREATMENT OUTCOME;

EID: 45149100437     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2007.02683.x     Document Type: Article

References (10)

1. Setoguchi S, Solomon DH, Weinblatt ME et al. Tumor necrosis factor α antagonist use and cancer in patients with rheumatoid arthritis. Arthritis Rheum 2006 54 : 2757 64.
2. Wolfe F, Michaud K. Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18572 patients. Arthritis Rheum 2004 50 : 1740 51.
3. Masaki Y, Sugai S. lymphoproliferative disorders in Sjogren's syndrome. Autoimmunity Rev 2004 3 : 175 82.
4. Harris NL, Swerdlow SH. Methotrexate-associated lymphoproliferative disorders. In : WHO Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues (Jaffe ES, Harris NL, Stein H, Vardiman JW, eds). Lyon : IARC Press, 2001 270 1.
5. Salloum E, Cooper DL, Howe G et al. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol 1996 14 : 1943 9.
6. Liote F, Pertuiset E, Cochand-Priollet B et al. Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis: role of Epstein-Barr virus infection. J Rheumatol 1995 22 : 1174 8.
7. Geborek P, Bladstrom A, Turesson C et al. Tumor necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas. Ann Rheum Dis 2005 64 : 699 703.
8. Askling J, Fored CM, Baecklund E et al. Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists. Ann Rheum Dis 2005 64 : 1414 20.
9. Scott DL, Kingsley GH. Tumor necrosis factor inhibitors for rheumatoid arthritis. N Engl J Med 2006 355 : 704 12.
10. Bongartz T, Sutton AJ, Sweeting MJ et al. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 2006 295 : 2275 85.